These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
349 related articles for article (PubMed ID: 32380660)
1. The Effect of Parenteral or Oral Iron Supplementation on Fatigue, Sleep, Quality of Life and Restless Legs Syndrome in Iron-Deficient Blood Donors: A Secondary Analysis of the IronWoMan RCT. Macher S; Herster C; Holter M; Moritz M; Matzhold EM; Stojakovic T; Pieber TR; Schlenke P; Drexler C; Amrein K Nutrients; 2020 May; 12(5):. PubMed ID: 32380660 [TBL] [Abstract][Full Text] [Related]
2. High-dose intravenously administered iron versus orally administered iron in blood donors with iron deficiency: study protocol for a randomised, controlled trial. Macher S; Drexler C; Lindenau I; Sareban N; Schlenke P; Amrein K Trials; 2016 Oct; 17(1):527. PubMed ID: 27793204 [TBL] [Abstract][Full Text] [Related]
3. High-dose intravenous versus oral iron in blood donors with iron deficiency: The IronWoMan randomized, controlled clinical trial. Drexler C; Macher S; Lindenau I; Holter M; Moritz M; Stojakovic T; Pieber TR; Schlenke P; Amrein K Clin Nutr; 2020 Mar; 39(3):737-745. PubMed ID: 30981629 [TBL] [Abstract][Full Text] [Related]
4. Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome. Bryant BJ; Yau YY; Arceo SM; Hopkins JA; Leitman SF Transfusion; 2013 Aug; 53(8):1637-44. PubMed ID: 23305102 [TBL] [Abstract][Full Text] [Related]
5. Open-label study of the efficacy and safety of intravenous ferric carboxymaltose in pregnant women with restless legs syndrome. Schneider J; Krafft A; Manconi M; Hübner A; Baumann C; Werth E; Gyr T; Bassetti C Sleep Med; 2015 Nov; 16(11):1342-1347. PubMed ID: 26498233 [TBL] [Abstract][Full Text] [Related]
6. [Iron deficiency, Fatigue and Restless-Legs-Syndrome]. Wurzinger B; König P Wien Med Wochenschr; 2016 Oct; 166(13-14):447-452. PubMed ID: 27577248 [TBL] [Abstract][Full Text] [Related]
7. Restless legs syndrome, pica, and iron status in blood donors. Spencer BR; Kleinman S; Wright DJ; Glynn SA; Rye DB; Kiss JE; Mast AE; Cable RG; Transfusion; 2013 Aug; 53(8):1645-52. PubMed ID: 23763445 [TBL] [Abstract][Full Text] [Related]
8. Randomized, placebo-controlled trial of ferric carboxymaltose in restless legs syndrome patients with iron deficiency anemia. Bae H; Cho YW; Kim KT; Allen RP; Earley CJ Sleep Med; 2021 Aug; 84():179-186. PubMed ID: 34157632 [TBL] [Abstract][Full Text] [Related]
9. TREATMENT OF ANEMIA AND IMPROVEMENT OF QUALITY OF LIFE AMONG PATIENTS WITH CROHN'S DISEASE: experience using ferric carboxymaltose. Sobrado CW; Cançado RD; Sobrado LF; Frugis MO; Sobrado MF Arq Gastroenterol; 2015 Dec; 52(4):255-9. PubMed ID: 26840464 [TBL] [Abstract][Full Text] [Related]
10. Investigating the response to intravenous iron in restless legs syndrome: an observational study. Hornyak M; Scholz H; Kiemen A; Kassubek J Sleep Med; 2012 Jun; 13(6):732-5. PubMed ID: 22503006 [TBL] [Abstract][Full Text] [Related]
11. Does Improvement of Low Serum Ferritin Improve Symptoms of Restless Legs Syndrome in a Cohort of Pediatric Patients? Rosen GM; Morrissette S; Larson A; Stading P; Barnes TL J Clin Sleep Med; 2019 Aug; 15(8):1149-1154. PubMed ID: 31482837 [TBL] [Abstract][Full Text] [Related]
12. Iron for restless legs syndrome. Trotti LM; Bhadriraju S; Becker LA Cochrane Database Syst Rev; 2012 May; 5(5):CD007834. PubMed ID: 22592724 [TBL] [Abstract][Full Text] [Related]
13. A Prospective Randomised Controlled Trial of a Single Intravenous Infusion of Ferric Carboxymaltose vs Single Intravenous Iron Polymaltose or Daily Oral Ferrous Sulphate in the Treatment of Iron Deficiency Anaemia in Pregnancy. Khalafallah AA; Hyppa A; Chuang A; Hanna F; Wilson E; Kwok C; Yan C; Gray Z; Mathew R; Falloon P; Dennis A; Pavlov T; Allen JC Semin Hematol; 2018 Oct; 55(4):223-234. PubMed ID: 30502851 [TBL] [Abstract][Full Text] [Related]
14. Multicentre randomized controlled trial comparing ferric(III)carboxymaltose infusion with oral iron supplementation in the treatment of preoperative anaemia in colorectal cancer patients. Borstlap WAA; Buskens CJ; Tytgat KMAJ; Tuynman JB; Consten ECJ; Tolboom RC; Heuff G; van Geloven N; van Wagensveld BA; C A Wientjes CA; Gerhards MF; de Castro SMM; Jansen J; van der Ven AWH; van der Zaag E; Omloo JM; van Westreenen HL; Winter DC; Kennelly RP; Dijkgraaf MGW; Tanis PJ; Bemelman WA BMC Surg; 2015 Jun; 15():78. PubMed ID: 26123286 [TBL] [Abstract][Full Text] [Related]
15. Ferric carboxymaltose in patients with restless legs syndrome and nonanemic iron deficiency: A randomized trial. Trenkwalder C; Winkelmann J; Oertel W; Virgin G; Roubert B; Mezzacasa A; Mov Disord; 2017 Oct; 32(10):1478-1482. PubMed ID: 28643901 [TBL] [Abstract][Full Text] [Related]
16. Prevalence of restless legs syndrome in female blood donors 1 week after blood donation. Pedrazzini B; Waldvogel S; Vaucher P; Cornuz J; Heinzer R; Tissot JD; Favrat B Vox Sang; 2014 Jul; 107(1):44-9. PubMed ID: 24329401 [TBL] [Abstract][Full Text] [Related]
17. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Van Wyck DB; Mangione A; Morrison J; Hadley PE; Jehle JA; Goodnough LT Transfusion; 2009 Dec; 49(12):2719-28. PubMed ID: 19682342 [TBL] [Abstract][Full Text] [Related]
18. Ferric carboxymaltose improves exercise capacity and quality of life in patients with pulmonary arterial hypertension and iron deficiency: a pilot study. Viethen T; Gerhardt F; Dumitrescu D; Knoop-Busch S; ten Freyhaus H; Rudolph TK; Baldus S; Rosenkranz S Int J Cardiol; 2014 Aug; 175(2):233-9. PubMed ID: 24880481 [TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: a multi-centred, placebo-controlled preliminary clinical trial. Allen RP; Adler CH; Du W; Butcher A; Bregman DB; Earley CJ Sleep Med; 2011 Oct; 12(9):906-13. PubMed ID: 21978726 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of ferric carboxymaltose (FCM) 500 mg dose for the treatment of Restless Legs Syndrome. Cho YW; Allen RP; Earley CJ Sleep Med; 2018 Feb; 42():7-12. PubMed ID: 29458749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]